December - 2022

top of page

NEWSROOM

Dec 6, 2022

4BIO Capital Portfolio Company Entact Bio Launches with $81 Million Series A

4BIO Capital Portfolio Company Entact Bio Launches with $81 Million Series A

Dec 1, 2022

SparingVision’s lead asset SPVN06 clears IND application in the US for retinitis pigmentosa

SparingVision’s lead asset SPVN06 clears IND application in the US for retinitis pigmentosa

bottom of page